Kristin Watson

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Peripheral arterial disease: a review of disease awareness and management
    Kristin Watson
    Department o f Pharmacy Practice and Sciences, University o f Maryland, School of Pharmacy, Baltimore, Maryland 21201, USA
    Am J Geriatr Pharmacother 4:365-79. 2006
  2. ncbi Depression in patients with heart failure: clinical implications and management
    Kristin Watson
    Department of Pharmacy Practice and Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA
    Pharmacotherapy 29:49-63. 2009
  3. ncbi Impact and clinical management of depression in patients with coronary artery disease
    Kelly M Summers
    Department of Pharmacy Practice and Science, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Pharmacotherapy 30:304-22. 2010
  4. ncbi Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention
    Kristin Watson
    Department of Pharmacy Practice and Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA
    Pharmacotherapy 27:647-56. 2007

Collaborators

  • Kelly M Summers
  • Kelly E Martin

Detail Information

Publications4

  1. ncbi Peripheral arterial disease: a review of disease awareness and management
    Kristin Watson
    Department o f Pharmacy Practice and Sciences, University o f Maryland, School of Pharmacy, Baltimore, Maryland 21201, USA
    Am J Geriatr Pharmacother 4:365-79. 2006
    ..Peripheral arterial disease (PAD) is a progressive atherosclerotic condition affecting approximately 27 million people in North America and Europe. Albeit a common clinical malady, it is underrecognized and undertreated...
  2. ncbi Depression in patients with heart failure: clinical implications and management
    Kristin Watson
    Department of Pharmacy Practice and Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA
    Pharmacotherapy 29:49-63. 2009
    ..Finally, clinicians should not avoid beta-blockers in those with a diagnosis of depression, as recent evidence demonstrates that these agents are not associated with inducing or worsening depressive symptoms...
  3. ncbi Impact and clinical management of depression in patients with coronary artery disease
    Kelly M Summers
    Department of Pharmacy Practice and Science, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Pharmacotherapy 30:304-22. 2010
    ....
  4. ncbi Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention
    Kristin Watson
    Department of Pharmacy Practice and Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA
    Pharmacotherapy 27:647-56. 2007
    ..To compare clinical outcomes and glycoprotein IIb-IIIa inhibitor use in patients undergoing percutaneous coronary intervention (PCI) who received bivalirudin or unfractionated heparin (UFH) in a real-world setting...